Formation of the
lipoxygenase-catalyzed metabolites of
arachidonic acid,
8-hydroxyeicosatetraenoic acid (8-HETE) and 12-hydroxyeicosatetraenoic
acid (12-HETE), and of the exocyclic
DNA adducts 1,N(6)-ethenodeoxyadenosine (epsilondA) and 3, N(4)-ethenodeoxycytidine (epsilondC) was investigated in NMRI mouse skin
carcinogenesis induced by 7,12-dimethylbenz[a]
anthracene (DMBA) and promoted by 12-O-tetradecanoylphorbol-13-acetate (TPA). In reversible
papillomas obtained after 20 weeks of TPA treatment, 15- and 68-fold higher contents of
8-HETE and
12-HETE, respectively, were observed, which were paralleled by 12- and 9-fold increased amounts of epsilondA and epsilondC, respectively. When compared to the level in vehicle-treated control skin, these elevations were statistically significant. In irreversible
papillomas harvested 20 weeks after the last TPA treatment, the levels of HETEs and etheno-
DNA adducts were found to be slightly reduced, as compared to those in reversible
papillomas, but were still increased over control levels in age-matched mice. Comparison of mean group values by simple regression analysis showed a close positive correlation between
HETE and etheno-
DNA adduct levels. Consistent with the miscoding properties of epsilondA causing mainly A --> T transversions, its increased formation in
papillomas could thus contribute to this type of mutation in
codon 61 of cHa-ras, shown to be a hallmark of DMBA-initiated and TPA-promoted mouse skin
carcinogenesis. Although direct evidence that etheno adducts are derived from
lipoxygenase-catalyzed metabolites of
arachidonic acid is missing, our results implicate DNA damage by oxidative stress and lipid peroxidation as a cause of genetic instability observed at late stages of
tumor promotion in mouse skin
carcinogenesis.